Lansoprazole
Product Images NDC 55648-140

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 55648-140). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wockhardt Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label (Lansodrotc15 Figure 01)

The front and back panels of Lansoprazole Delayed-Release Capsules, USP, 15 mg by Wockhardt Limited. The front panel shows the product name, strength, and a depiction of 14 capsules for a one 14-day course of treatment. The back panel includes directions for use, instructions on repeated courses, storage information, and a contact number for questions. The label emphasizes the delayed-release nature and the acid reducer indication.*

FDA Label Image

Bottle Carton (Lansodrotc15 Figure 02)

Lansoprazole Delayed-Release Capsules, USP 15 mg by Wockhardt Limited packaging label. The label states it contains 14 capsules, representing a one 14-day course of treatment. It also notes the product is an acid reducer and sodium free. Directions, drug facts, warnings, inactive ingredients, and manufacturer details appear on the label with typical drug information and usage instructions.*

FDA Label Image

Bottle Carton (Lansodrotc15 Figure 03)

Box packaging for Lansoprazole Delayed-Release Capsules, USP, 15 mg by Wockhardt Limited. The label states the product is an acid reducer with 28 capsules inside two bottles, intended for a two 14-day course of treatment. The label includes drug facts, usage instructions, warnings, inactive ingredients, and manufacturer and distributor information.*

FDA Label Image

Bottle Carton (Lansodrotc15 Figure 04)

The Lansoprazole Delayed-Release Capsules, USP 15 mg carton label from Wockhardt Limited displays that the package contains 3 bottles with a total of 42 capsules, amounting to three 14-day courses of treatment. The label highlights the product as an acid reducer and provides dosing and safety information, including drug facts and warnings, as part of the carton exterior. The packaging also displays the NDC 64679-140-09 and includes manufacturer and distributor details.*

FDA Label Image

Bottle Label (Lansodrotc15 Figure 05)

Drug Facts panel for Lansoprazole Delayed-Release Capsules USP 15 mg as an acid reducer, detailing active ingredient, usage instructions, warnings, directions for a 14-day treatment course, inactive ingredients, and manufacturer/distributor information from Wockhardt Limited and Wockhardt USA LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.